TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

sturti TransMedics Group (NASDAQ:TMDX) had a remarkable second quarter, with another beat & raise. It's tough to say what the market thinks of the results, as the stock initially popped double-digits in the after-hours, but then came back down to being up just ~6% as the broad market sell-off intensified. There are three key questions I'm monitoring as TransMedics continues to execute its long-term plan. Let's dive in. Introduction To TransMedics I wrote my first article covering TransMedics back in March, ...